Kenya takes a strong stand in Covid-19 vaccinations to minimize the spread of the disease

Kenya identified its first case of Covid-19 on 12th March 2020. It has since then undertaken a series of measures to contain the spread and management of the disease in the country. In a population of approximately 54 million there were 323, 140 confirmed cases and 5,644 COVID-deaths as of 10th March 2022. The confirmed cases are cases identified with laboratory confirmation (by the use of PCR) of COVID-19 infection, irrespective of clinical signs and symptoms. Vaccination of the adult population against Covid-19 started in March 2021 and the teenage population in November 2021. Global reports of waning immunity and protection from Covid-19 encouraged Kenya to administer 3rd doses as booster shots early on and aims to administer 4.2 million booster shots by June 2022 to all eligible adults. Kenya relies on five COVID-19 vaccines that are manufactured by AstraZeneca, Moderna, Johnson & Johnson, Pfizer, and Sinopharm. They are primarily delivered through...